End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community Hospital.
Masato KokajiNaoto ImotoMiki WatanabeYutaro SuzukiShinji FujiwaraRie ItoToshiyasu SakaiSatomi YamamotoIsamu SugiuraShingo KurahashiPublished in: Palliative medicine reports (2023)
Patients with AML tend to have lesser access to specialized palliative care and fewer options for their place of death than those with DLBCL. Detailed EOL care plans are needed for these patients, considering the characteristics of the disease.
Keyphrases
- palliative care
- acute myeloid leukemia
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- diffuse large b cell lymphoma
- mental health
- squamous cell carcinoma
- emergency department
- allogeneic hematopoietic stem cell transplantation
- acute lymphoblastic leukemia
- patient reported outcomes
- patient reported